Medtronic plc, the global leader in medical technology, announced that it has entered into a definitive agreement with Intersect ENT, a global ear, nose, and throat medical technology leader dedicated to transforming patient care, in which Medtronic will acquire all outstanding shares of Intersect ENT for $28.25 per share in an all-cash transaction implying an enterprise value of approximately $1.1 billion.
August 6, 2021
· 12 min read